# Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial (0653-151)

> **NCT00652444** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 120 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** ezetimibe
- **DRUG:** simvastatin
- **DRUG:** Placebo (Unspecified)

## Key facts

- **NCT ID:** NCT00652444
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2004-08
- **Final completion:** 2004-08
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2022-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00652444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00652444, "Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial (0653-151)". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00652444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*